title: Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Marmor
authors.forename: Ronald E
authors.initials: RE
authors.lastname: Carr
authors.forename: Michael
authors.initials: M
authors.lastname: Easterbrook
authors.forename: Ayad A
authors.initials: AA
authors.lastname: Farjo
authors.forename: William F
authors.initials: WF
authors.lastname: Mieler
mesh_terms: D000047:Academies and Institutes; D018501:Antirheumatic Agents / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects; D003941:Diagnostic Techniques, Ophthalmological / Q000592:standards; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D009885:Ophthalmology; D017410:Practice Guidelines as Topic; D012160:Retina / Q000187:drug effects*; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D014481:United States
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine; D002738:Chloroquine